CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda
New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed combination relates to acquisition by Berhyanda Limited (Acquirer) for up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited (Target), by way of a […] More